ArticlePloS one2014

Purified dendritic cell-tumor fusion hybrids supplemented with non-adherent dendritic cells fraction are superior activators of antitumor immunity.

Yunfei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.